Flagship hospital has only “followed the data”

A few weeks ago we reported that a major U.S. hospital is adopting Deltex’s ODM technology. The hospital had made a clinical decision based on its own evidence that haemodynamic monitoring using Oesophageal Doppler makes sense on all levels. It shortens hospital stays and delivers patient benefits and healthcare provider efficiencies. While this was good news for Deltex, it was also unsurprising, because reams of clinical studies say the same thing.

The overwhelming evidence says that managing patients’ fluid levels in the perioperative and critical care settings improves outcomes. Even patients considered to be at moderate haemodynamic risk can suffer fluid shifts with significant adverse consequences. Resulting conditions, are exemplified by the incidence of acute kidney injury in patients who entered the hospital with healthy kidneys!

Deltex’s contention is that a safety-first mindset dictates a monitoring-for-all approach. The new, fully enabled ODM+ platform, features all the best-in-class haemodynamic monitoring technologies, including non-invasive options. As such, the clinician can choose to monitor all patients and intervene only when required, guided by accurate, real-time patient data.

To adopt a monitoring-for-all stance patently leads to better outcomes for patients, shorter hospital stays and lower healthcare costs. And remember, it’s not just Deltex saying this… it’s big data.

The challenge, however, has always been to join those dots in a hospital setting. Not all institutions have the wherewithal to close the data gap that exists between a seemingly successful surgical outcome and subsequent length of hospital stay. When they do, as we’ve seen recently, the rewards are obvious.

Ewan Phillips, Deltex Medical’s Chief Executive, commented: “The results from the U.S. hospital’s evaluation further support the use of oesophageal Doppler monitoring, even in those hospitals that already have the very best patient outcomes. It is noteworthy that this hospital was able to use ODM to improve its patients’ recoveries even though its starting points for lengths of stay for these types of surgery were already around half the NHS England average.”

Deltex Medical is an authority in haemodynamic monitoring. The Deltex ODM+ oesophageal Doppler monitoring system is widely acknowledged as the technology leader because it directly measures cardiac output at source. This means the data it delivers to the clinician are both accurate and real-time. The benefits, while elusive because of the difficulties of joined-up data gathering, are tangible.  

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:


Registered in England & Wales Company No: 1691369